| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Matinas Biopharma Holdings, Inc. (MTNB) has 0 insiders with recent SEC Form 4 filings, including 7 buys and 0 sells. MTNB is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Sep 11, 2017 | Mannino Raphael J | Chief Scientific Officer | Buy | 5,000 | $1.41 | $7,050.00 | +0.4% | |
| Sep 8, 2017 | Rongen Roelof | Chief Executive Officer | Buy | 5,000 | $1.36 | $6,800.00 | +0.1% | |
| Sep 8, 2017 | Stern Adam K | Director | Buy | 100,000 | $1.38 | $138,000.00 | +1.4% | |
| Sep 7, 2017 | Scibetta James S | Director | Buy | 5,000 | $1.29 | $6,450.00 | +1.2% | |
| Sep 7, 2017 | Conrad Herbert J | Director | Buy | 100,000 | $1.30 | $130,000.00 | +2.6% | |
| Sep 7, 2017 | Ferrari Stefano | Director | Buy | 5,000 | $1.24 | $6,200.00 | +2.5% |